SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017411
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:50
Documents
82
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20230930x10q.htm   iXBRL 10-Q 1379363
2 EX-10.1 imgn-20230930xex10d1.htm EX-10.1 100149
3 EX-10.2 imgn-20230930xex10d2.htm EX-10.2 24256
4 EX-31.1 imgn-20230930xex31d1.htm EX-31.1 10923
5 EX-31.2 imgn-20230930xex31d2.htm EX-31.2 10935
6 EX-32 imgn-20230930xex32.htm EX-32 10169
  Complete submission text file 0001558370-23-017411.txt   7415266

Data Files

Seq Description Document Type Size
7 EX-101.SCH imgn-20230930.xsd EX-101.SCH 63908
8 EX-101.CAL imgn-20230930_cal.xml EX-101.CAL 38156
9 EX-101.DEF imgn-20230930_def.xml EX-101.DEF 297933
10 EX-101.LAB imgn-20230930_lab.xml EX-101.LAB 481635
11 EX-101.PRE imgn-20230930_pre.xml EX-101.PRE 448258
76 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20230930x10q_htm.xml XML 1071070
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 231372214
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences